Former investor darling Ginkgo Bioworks is facing layoffs and plummeting share prices, prompting the company to launch new services in artificial intelligence for biological research. The company announced a new AI model and a data service for academic researchers and companies to develop their own models. However, experts are skeptical about Ginkgo’s ability to compete in this space as there is already strong competition. The company’s new efforts aim to leverage neural networks and machine learning to design therapies and improve research speed. Despite their efforts, it remains unclear how much advantage the struggling company can offer.
Source link
Ginkgo Bioworks makes a bet on AI, hoping for a turnaround
